Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jitka Fucikova

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Trends in Cancer|September 1, 2023
Interferon signaling restrains renal cell carcinoma heterogeneityPeter Holicek, Jitka Fucikova, Lorenzo Galluzzi
Cell Research|August 1, 2020
Calreticulin and cancerJitka Fucikova, Radek Spisek, Guido Kroemer, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinomaIva Truxova, David Cibula, Radek Spisek, et al.
Oncoimmunology|February 1, 2020
Calreticulin arms NK cells against leukemiaJitka Fucikova, Justin P Kline, Lorenzo Galluzzi, et al.
Frontiers in Immunology|November 19, 2019
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical ApplicationsJitka Fucikova, Lenka Palova-Jelinkova, Jirina Bartunkova, et al.
Oncoimmunology|October 25, 2019
Apoptotic caspases cut down the immunogenicity of radiationAitziber Buqué, Maria Esperanza Rodriguez-Ruiz, Jitka Fucikova, et al.
Oncoimmunology|May 13, 2015
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapyIrena Adkins, Jitka Fucikova, Abhishek D Garg, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2012
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapyAshley J Knights, Jitka Fucikova, Anupama Pasam, et al.
Immunology Letters|April 15, 2014
Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCsIva Truxova, Katerina Pokorna, Kamila Kloudova, et al.
Immunology Letters|November 28, 2017
Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancerJitka Fucikova, Lenka Kasikova, Iva Truxova, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Trends in Cancer|September 1, 2023
Interferon signaling restrains renal cell carcinoma heterogeneityPeter Holicek, Jitka Fucikova, Lorenzo Galluzzi
Cell Research|August 1, 2020
Calreticulin and cancerJitka Fucikova, Radek Spisek, Guido Kroemer, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinomaIva Truxova, David Cibula, Radek Spisek, et al.
Oncoimmunology|February 1, 2020
Calreticulin arms NK cells against leukemiaJitka Fucikova, Justin P Kline, Lorenzo Galluzzi, et al.
Frontiers in Immunology|November 19, 2019
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical ApplicationsJitka Fucikova, Lenka Palova-Jelinkova, Jirina Bartunkova, et al.
Oncoimmunology|October 25, 2019
Apoptotic caspases cut down the immunogenicity of radiationAitziber Buqué, Maria Esperanza Rodriguez-Ruiz, Jitka Fucikova, et al.
Oncoimmunology|May 13, 2015
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapyIrena Adkins, Jitka Fucikova, Abhishek D Garg, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2012
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapyAshley J Knights, Jitka Fucikova, Anupama Pasam, et al.
Immunology Letters|April 15, 2014
Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCsIva Truxova, Katerina Pokorna, Kamila Kloudova, et al.
Immunology Letters|November 28, 2017
Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancerJitka Fucikova, Lenka Kasikova, Iva Truxova, et al.
Pageof 7